Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Dusan Kolar. (2018) Addictive potential of novel treatments for refractory depression and anxiety. Neuropsychiatric Disease and Treatment 14, pages 1513-1519.
Read now
Read now
Articles from other publishers (64)
Sandy Maumus-Robert, Ana Jarne-Munoz, Marie Tournier, Bernard Bégaud & Antoine Pariente. (2023) Trajectories of Benzodiazepine Use among Older Adults from a Concordance-with-Guidelines Perspective: A Nationwide Cohort Study. Drugs & Aging 40:10, pages 919-931.
Crossref
Crossref
Tian-Tian Ma, Zixuan Wang, Xiwen Qin, Chengsheng Ju, Wallis C Y Lau, Kenneth K C Man, David Castle, Wing Chung Chang, Adrienne Y L Chan, Edmund C L Cheung, Celine Sze Ling Chui & Ian C K Wong. (2023) Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysis. SLEEP.
Crossref
Crossref
Felipe Maraucci Ribeiro de Mendonça, Giulia Paulo Rossi Ribeiro de Mendonça, Laura Costa Souza, Lucas Pequeno Galvão, Henrique Soares Paiva, Cintia de Azevedo Marques Périco, Julio Torales, Antonio Ventriglio, João Maurício Castaldelli-Maia & Anderson Sousa Martins Silva. (2023) Benzodiazepines and Sleep Architecture: A Systematic Review. CNS & Neurological Disorders - Drug Targets 22:2, pages 172-179.
Crossref
Crossref
Kristien Coteur, Pavlos Mamouris, Bert Vaes, Marc Van Nuland, Catharina Matheï & Birgitte Schoenmakers. (2022) Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study. Frontiers in Public Health 10.
Crossref
Crossref
Manuel Camino, Encarnacion Satorres, Iraida Delhom, Elena Real, Mireia Abella & Juan C. Meléndez. (2022) Mindfulness-based Cognitive Therapy to Improve Sleep Quality in Older Adults with Insomnia. Psychosocial Intervention 31:3, pages 159-167.
Crossref
Crossref
Francisco Torres-Bondia, Farida Dakterzada, Leonardo Galván, Miquel Buti, Gaston Besanson, Eric Grill, Roman Buil, Jordi de Batlle & Gerard Piñol-Ripoll. (2022) Benzodiazepine and Z-Drug Use and the Risk of Developing Dementia. International Journal of Neuropsychopharmacology 25:4, pages 261-268.
Crossref
Crossref
Eunyoung Lee, Youngrong Bang, In-Young Yoon & Ha-Yun Choi. (2022) Entrapment of Binaural Auditory Beats in Subjects with Symptoms of Insomnia. Brain Sciences 12:3, pages 339.
Crossref
Crossref
Patrícia Ferreira, Ana Rita Ferreira, Beatriz Barreto & Lia Fernandes. (2021) Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews. European Geriatric Medicine 13:1, pages 19-32.
Crossref
Crossref
Marie Tournier, Elodie Pambrun, Sandy Maumus‐Robert, Antoine Pariente & Hélène Verdoux. (2021) The risk of dementia in patients using psychotropic drugs: Antidepressants, mood stabilizers or antipsychotics. Acta Psychiatrica Scandinavica 145:1, pages 56-66.
Crossref
Crossref
Ana Carolina Aguilar & Cristina Frange. 2022. Sleep Medicine and Physical Therapy. Sleep Medicine and Physical Therapy
53
59
.
Geoffrey Joyce, Patricia Ferido, Johanna Thunell, Bryan Tysinger & Julie Zissimopoulos. (2022) Benzodiazepine use and the risk of dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Crossref
Kazumichi Hashimoto. (2021) The relationship between cognitive function and sleep disturbance認知機能と睡眠障害の関連. Tenri Medical Bulletin 24:2, pages 118-122.
Crossref
Crossref
Mathilde Bonnay, Thomas Soeiro, Rachel Megard, Joelle Micallef, Benjamin Rolland & Mathieu Chappuy. (2021) Usages et bon usage des benzodiazépines anxiolytiques et hypnotiques. Annales Médico-psychologiques, revue psychiatrique 179:8, pages 748-756.
Crossref
Crossref
Roberta Magalhães Bellora, Vanessa Sgnaolin, Paula Engroff, Letícia Güenter Dannebrock, Edgar Chagas Diefenthaeler & Alfredo Cataldo Neto. (2021) Transtornos de Ansiedade em Idosos. PAJAR - Pan American Journal of Aging Research 9:1, pages e40528.
Crossref
Crossref
Miguel Germán Borda, Alberto Jaramillo‐Jimenez, Ragnhild Oesterhus, Jose Manuel Santacruz, Diego Alejandro Tovar‐Rios, Hogne Soennesyn, Carlos Alberto Cano‐Gutierrez, Audun Osland Vik‐Mo & Dag Aarsland. (2021) Benzodiazepines and antidepressants: Effects on cognitive and functional decline in Alzheimer's disease and Lewy body dementia. International Journal of Geriatric Psychiatry 36:6, pages 917-925.
Crossref
Crossref
T. Scott Stroup, Mark Olfson, Cecilia Huang, Melanie M. Wall, Terry Goldberg, Davangere P. Devanand & Tobias Gerhard. (2021) Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia. JAMA Psychiatry 78:6, pages 632.
Crossref
Crossref
Stefania Chiappini, Fabrizio Schifano, Giovanni Martinotti, Johanna C. Strasser, Udo Bonnet & Norbert Scherbaum. (2021) Opioid painkiller dependence in a sample of elderly medical inpatients. Psychogeriatrics 21:3, pages 265-271.
Crossref
Crossref
Stephan Mühlig & Dirk K. Wolter. 2021. Praxishandbuch Gerontopsychiatrie und -Psychotherapie. Praxishandbuch Gerontopsychiatrie und -Psychotherapie
201
234
.
Laura Mantoan Ritter & Christer Nilsson. 2021. Management of Patients with Dementia. Management of Patients with Dementia
251
290
.
Hayun Choi, Soyoung Youn, Yoo Hyun Um, Tae Won Kim, Gawon Ju, Hyuk Joo Lee, Chungsuk Lee, Sang Don Lee, Kyungyeol Bae, Seong Jae Kim, Ji Hyun Lee, Tae Kim & Seockhoon Chung. (2020) Korean Clinical Practice Guideline for the Diagnosis and Treatment of Insomnia in Adults. Psychiatry Investigation 17:11, pages 1048-1059.
Crossref
Crossref
Linzi Liu, Linna Jia, Peiying Jian, Yifang Zhou, Jian Zhou, Feng Wu & Yanqing Tang. (2020) The Effects of Benzodiazepine Use and Abuse on Cognition in the Elders: A Systematic Review and Meta-Analysis of Comparative Studies. Frontiers in Psychiatry 11.
Crossref
Crossref
Hélène Jacqmin-Gadda, Florian Guillet, Clément Mathieu, Catherine Helmer, Antoine Pariente & Pierre Joly. (2020) Impact of benzodiazepine consumption reduction on future burden of dementia. Scientific Reports 10:1.
Crossref
Crossref
David S. Baldwin & Nathan T. M. Huneke. 2020. Seminars in Clinical Psychopharmacology. Seminars in Clinical Psychopharmacology
268
289
.
Lone Baandrup. (2020) Polypharmacy in schizophrenia. Basic & Clinical Pharmacology & Toxicology 126:3, pages 183-192.
Crossref
Crossref
Arnaud Panes, Hélène Verdoux, Annie Fourrier‐Réglat, Driss Berdaï, Antoine Pariente & Marie Tournier. (2020) Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disorders. British Journal of Clinical Pharmacology 86:3, pages 601-610.
Crossref
Crossref
Christopher N. Kaufmann, Alison A. Moore, Mark W. Bondi, James D. Murphy, Atul Malhotra & Laura A. Hart. (2020) Association Between the Use of Non-benzodiazepine Hypnotics and Cognitive Outcomes: A Systematic Review. Current Sleep Medicine Reports 6:1, pages 11-20.
Crossref
Crossref
Miren Ettcheto, Jordi Olloquequi, Elena Sánchez-López, Oriol Busquets, Amanda Cano, Patricia Regina Manzine, Carlos Beas-Zarate, Rubén D. Castro-Torres, Maria Luisa García, Mónica Bulló, Carme Auladell, Jaume Folch & Antonio Camins. (2020) Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Charles D. Ciccone. 2020. Guccione's Geriatric Physical Therapy. Guccione's Geriatric Physical Therapy
102
136
.
Thomas Desmidt, Julien Delrieu, Thibaud Lebouvier, Gabriel Robert, Renaud David, Anna-Chloé Balageas, Alexandre Surget, Catherine Belzung, Nicolas Arlicot, Maria-Joao Ribeiro, Pierre Payoux, Bruno Vellas, Wissam El-Hage, Elsa Tavernier & Vincent Camus. (2019) Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort. Neurobiology of Aging 84, pages 61-69.
Crossref
Crossref
Romain Barus, Johana Béné, Julie Deguil, Sophie Gautier & Régis Bordet. (2019) Drug interactions with dementia‐related pathophysiological pathways worsen or prevent dementia. British Journal of Pharmacology 176:18, pages 3413-3434.
Crossref
Crossref
Gerd Kempermann. (2019) Making DEEP Sense of Lifestyle Risk and Resilience. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Erkki Kronholm, Pekka Jousilahti, Tiina Laatikainen, Tea Lallukka, Markku Peltonen, Johanna Seppänen & Lauri Virta. (2019) Trajectories in hypnotic use and approaching death: a register linked case–control study. Sleep Medicine 57, pages 153-161.
Crossref
Crossref
Stephen T. Chen, Dax Volle, Jason Jalil, Pauline Wu & Gary W. Small. (2019) Health-Promoting Strategies for the Aging Brain. The American Journal of Geriatric Psychiatry 27:3, pages 213-236.
Crossref
Crossref
Sharon L. Crowell‐Davis, Thomas F. Murray & Leticia Mattos DantasLeticia Mattos Dantas & Sharon L. Crowell‐Davis. 2019. Veterinary Psychopharmacology. Veterinary Psychopharmacology
67
102
.
Egemen Savaskan & Marc Walter. 2019. Suchtmedizin. Suchtmedizin
359
367
.
Elsa Bourcier, Amandine Baptiste, Adrien Borowik, Lucas Zerbib, Dominique Bonnet-Zamponi, Florence Tubach, Christine Fernandez & Patrick Hindlet. (2018) Sedative-hypnotic initiation and renewal at discharge in hospitalized older patients: an observational study. BMC Geriatrics 18:1.
Crossref
Crossref
Rajesh R Tampi, Deena J Tampi, Juan J Young & Ashmita Banerjee. (2018) Benzodiazepine use and the risk for dementia. Future Neurology 13:4, pages 209-217.
Crossref
Crossref
Rosa Camila Lucchetta, Barbara Paes Miglioli da Mata & Patricia de Carvalho Mastroianni. (2018) Association between Development of Dementia and Use of Benzodiazepines: A Systematic Review and Meta-Analysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38:10, pages 1010-1020.
Crossref
Crossref
Fábio José Fabrício de Barros Souza, Giliane Franco de Lima, Franciele Tibola, Giancarlo Lucca & Kristian Madeira. (2018) Avaliação do padrão de sono em insones usuários de benzodiazepínicos e análise da trazodona como medicação substitutiva. Jornal Brasileiro de Psiquiatria 67:2, pages 80-86.
Crossref
Crossref
Brendan J. Ng, David G. Le Couteur & Sarah N. Hilmer. (2018) Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients. Drugs & Aging 35:6, pages 493-521.
Crossref
Crossref
Ross Penninkilampi & Guy D. Eslick. (2018) A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias. CNS Drugs 32:6, pages 485-497.
Crossref
Crossref
Hervé Javelot, Anne Marquis, Emilie Antoine-Bernard, Jean Grandidier, Luisa Weiner, Thierry Javelot & Bruno Michel. (2018) Benzodiazepines Withdrawal: Initial Outcomes and Long-Term Impact on Falls in a French Nursing Home. Pharmacy 6:2, pages 30.
Crossref
Crossref
Elsa Bourcier, Virginie Korb-Savoldelli, Gilles Hejblum, Christine Fernandez & Patrick Hindlet. (2018) A systematic review of regulatory and educational interventions to reduce the burden associated with the prescriptions of sedative-hypnotics in adults treated for sleep disorders. PLOS ONE 13:1, pages e0191211.
Crossref
Crossref
Gloria Ortiz-Guerrero, Diana Amador-Muñoz, Carlos Alberto Calderón-Ospina, Daniel López-Fuentes & Mauricio Orlando Nava Mesa. (2018) Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences. Neural Plasticity 2018, pages 1-9.
Crossref
Crossref
Rajesh R. Tampi, Deena J. Tampi, Wynnelena C. Canio, Poorvanshi Alag, Dhweeja Dasarathy & Joel P. Dey. 2018. Psychiatric Disorders Late in Life. Psychiatric Disorders Late in Life
139
165
.
Jaden Brandt & Christine Leong. (2017) Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research. Drugs in R&D 17:4, pages 493-507.
Crossref
Crossref
Tsz-tai Chan, William Chun-yin Leung, Victor Li, Kin-yiu Wesley Wong, Wing-ming Chu, Ka-chun Leung, Yuey-zhun Ng, Yuen-ming Gary Kai, Yat-fung Shea, Shek-kwan Richard Chang & Leung-wing Chu. (2017) Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study. Psychogeriatrics 17:5, pages 310-316.
Crossref
Crossref
Julien Bezin, Pauline Bosco-Levy & Antoine Pariente. (2017) False-positive results in pharmacoepidemiology and pharmacovigilance. Therapies 72:4, pages 415-420.
Crossref
Crossref
Mariana Macedo Alvim, Danielle Teles da Cruz, Marcel de Toledo Vieira, Ronaldo Rocha Bastos & Isabel Cristina Gonçalves Leite. (2017) Prevalence of and factors associated with benzodiazepine use in community-resident elderly persons. Revista Brasileira de Geriatria e Gerontologia 20:4, pages 463-473.
Crossref
Crossref
Mariana Martins Gonzaga do Nascimento, Juliana Vaz de Melo Mambrini, Maria Fernanda Lima-Costa, Josélia Oliveira Araújo Firmo, Sérgio William Viana Peixoto & Antônio Ignácio de Loyola Filho. (2017) Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. European Journal of Clinical Pharmacology 73:5, pages 615-621.
Crossref
Crossref
Tilman Wetterling & Klaus Junghanns. (2017) Substance Abuse in Older Psychiatric Inpatients. SUCHT 63:2, pages 115-121.
Crossref
Crossref
Dirk K. Wolter. (2017) Suchtpotenzial und andere Risiken von Benzodiazepinen und Z-Drugs im Alter. SUCHT 63:2, pages 81-97.
Crossref
Crossref
Anne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, Fabienne Bazin, Hélène Verdoux, Marie Tournier, Bernard Bégaud & Antoine Pariente. (2017) Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study. Pharmacoepidemiology and Drug Safety 26:2, pages 162-169.
Crossref
Crossref
I. Anghelescu & O. Benkert. 2017. Kompendium der Psychiatrischen Pharmakotherapie. Kompendium der Psychiatrischen Pharmakotherapie
479
528
.
Michael Liebrenz, Marcel Schneider, Anna Buadze, Marie-Therese Gehring, Anish Dube & Carlo Caflisch. (2016) Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study. Harm Reduction Journal 13:1.
Crossref
Crossref
Michelle G Craske & Murray B Stein. (2016) Anxiety. The Lancet 388:10063, pages 3048-3059.
Crossref
Crossref
Willy Gomm, Klaus von Holt, Friederike Thomé, Karl Broich, Wolfgang Maier, Klaus Weckbecker, Anne Fink, Gabriele Doblhammer & Britta Haenisch. (2016) Regular Benzodiazepine and Z-Substance Use and Risk of Dementia: An Analysis of German Claims Data. Journal of Alzheimer's Disease 54:2, pages 801-808.
Crossref
Crossref
Martin Aigner. (2016) Benzodiazepine im FokusBenzodiazepines in focus. psychopraxis. neuropraxis 19:4, pages 115-117.
Crossref
Crossref
Fanny Etchepare, Elodie Pambrun, Bernard Bégaud, Hélène Verdoux & Marie Tournier. (2016) Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients. Fundamental & Clinical Pharmacology 30:1, pages 82-92.
Crossref
Crossref
Ashakumary Lakshmikuttyamma, Sidhartha D. Ray & Abigail Kay. 2016.
Murray B. Stein & Jitender Sareen. (2015) Generalized Anxiety Disorder. New England Journal of Medicine 373:21, pages 2059-2068.
Crossref
Crossref
S. Billioti De Gage. (2020) Benzodiazépines et risque de démence chez les sujets âgés. European Psychiatry 30:S2, pages S44-S45.
Crossref
Crossref
Esa R. Korpi, Bjørnar den Hollander, Usman Farooq, Elena Vashchinkina, Ramamoorthy Rajkumar, David J. Nutt, Petri Hyytiä & Gavin S. Dawe. (2015) Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacological Reviews 67:4, pages 872-1004.
Crossref
Crossref
Suzanne Nielsen. 2017. Non-medical and illicit use of psychoactive drugs. Non-medical and illicit use of psychoactive drugs
141
159
.